This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Accidental poisoning by and exposure to alcohol
VWXY20_ACCIDENTAL_POISO_EXPOS_ALCOHOL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
717 |
4. Check minimum number of eventsNone |
717 |
5. Include endpointsNone |
717 |
6. Filter based on genotype QC (FinnGen only) |
717 |
Control definitions (FinnGen only)
- Control exclude
- CD2_BENIGN_FEMALE_GEN_OTH
Extra metadata
- Level in the ICD hierarchy
- 5
- Special
- ALCOPOISACCI
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- X40-X49
Similar endpoints
↥List of similar endpoints to
Accidental poisoning by and exposure to alcohol
based on the number of shared cases.
Similar with more cases:
- Alcohol related diseases, tilastokeskus definition
- Alcohol related diseases and deaths, all endpoints
- Other external causes of accidental injury
- Accidents
- External causes of morbidity and mortality
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 717 | 345 | 372 |
| Unadjusted period prevalence (%) | 0.14 | 0.12 | 0.16 |
| Median age at first event (years) | 33.85 | 15.54 | 50.84 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 642
- Matched controls
- 6418
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T51.0
ICD-10 Finland
Toxic effect: Ethanol
667.1
323.0
311
9
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
+∞
323.0
642
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
15.9
119.5
208
188
T36
ICD-10 Finland
Poisoning by systemic antibiotics
13.7
94.5
174
170
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
13.6
76.9
140
129
T51.9
ICD-10 Finland
Toxic effect: Alcohol, unspecified
550.2
52.2
51
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
15.8
49.2
82
59
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
17.9
47.4
75
47
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
13.3
42.5
76
64
N05AH04
ATC
quetiapine; oral
4.0
41.8
203
669
N07BB01
ATC
disulfiram; oral
8.5
38.7
88
117
F10.20
ICD-10 Finland
Alcohol dependence currently independent
17.2
38.2
61
39
P15
ICPC
Chronic alcohol abuse
11.4
34.5
66
64
F10.25
ICD-10 Finland
Alcohol dependence continuous use
17.6
33.0
52
32
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
27.0
31.4
43
17
A98
ICPC
Health maint/preventive medicine
0.3
30.9
460
5741
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
12.2
30.4
56
50
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
15.1
26.5
44
31
N06AX11
ATC
mirtazapine; oral
2.6
25.5
237
1165
T51.8
ICD-10 Finland
Toxic effect: Other alcohols
+∞
25.2
24
*
F10.24
ICD-10 Finland
Alcohol depence active use
14.4
24.9
42
31
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.1
24.5
154
586
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
19.0
23.7
36
20
N05AA02
ATC
levomepromazine; systemic
6.1
22.5
63
112
N05BA02
ATC
chlordiazepoxide; systemic
10.2
22.1
44
46
N05AH03
ATC
olanzapine; systemic
4.3
22.1
86
221
T51.1
ICD-10 Finland
Toxic effect: Methanol
+∞
22.0
21
*
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
19.7
21.5
32
17
Z72.1
ICD-10 Finland
Alcohol use
14.2
20.7
35
26
Y91.1
ICD-10 Finland
Moderate alcohol intoxication
113.7
20.7
22
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.0
20.7
131
498
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
37.1
20.0
25
7
N06AB03
ATC
fluoxetine; oral
3.2
19.7
111
388
P16
ICPC
Acute alcohol abuse
9.0
18.9
40
47
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
7.2
18.5
45
66
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.7
18.4
85
254
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
15.9
18.1
29
19
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
13.5
18.1
31
24
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.7
17.9
63
146
N05BA01
ATC
diazepam; systemic, rectal
3.1
17.7
108
397
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
8.9
17.4
37
44
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.5
16.7
83
263
N05BA04
ATC
oxazepam; oral
2.3
16.5
176
892
N06AB04
ATC
citalopram; systemic
2.6
16.4
138
617
N05CF01
ATC
zopiclone; oral
2.3
16.2
187
982
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
48.8
16.1
19
*
S06.0
ICD-10 Finland
Concussion
3.0
16.0
98
360
K70.0
ICD-10 Finland
Alcoholic fatty liver
39.1
15.5
19
5
Y91.2
ICD-10 Finland
Severe alcohol intoxication
46.2
15.1
18
*
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
9.8
15.1
30
32
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.0
14.7
61
166
N05CD07
ATC
temazepam; oral
3.2
14.4
80
275
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
14.3
186
1025
SPAT1265
SPAT
Breathalyser
13.1
14.0
24
19
N05AX08
ATC
risperidone; systemic
3.3
13.9
72
235
N06AB06
ATC
sertraline; oral
2.8
13.9
96
381
AA1AD
NOMESCO Finland
CT of head and brain
2.3
13.6
135
655
Y91.0
ICD-10 Finland
Mild alcohol intoxication
142.8
13.5
14
*
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.6
13.4
107
461
X59
ICD-10 Finland
Exposure to unspecified factor
2.3
13.3
140
696
P19
ICPC
Drug abuse
7.8
13.3
30
40
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.6
13.2
38
71
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.7
12.8
95
391
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
10.8
12.8
24
23
B18.2
ICD-10 Finland
Chronic viral hepatitis C
7.5
12.6
29
40
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
13.5
12.5
21
16
F92.0
ICD-10 Finland
Depressive conduct disorder
11.9
12.4
22
19
N05BA12
ATC
alprazolam; oral
3.2
12.1
66
224
N05AD01
ATC
haloperidol; systemic
5.7
12.1
34
62
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
27.3
12.1
16
6
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.9
11.9
49
133
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
11.9
96
417
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
5.7
11.8
33
60
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
6.0
11.8
32
56
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.8
11.8
50
140
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
8.3
11.7
25
31
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.1
11.6
31
53
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
8.8
11.1
23
27
N05AX12
ATC
aripiprazole; systemic
3.5
11.0
52
159
K92.0
ICD-10 Finland
Haematemesis
6.0
10.8
29
50
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
18.2
10.8
16
9
SPAT1227
SPAT
Substance abuse rehabilitation
13.2
10.7
18
14
N06AA12
ATC
doxepin; systemic
4.1
10.6
41
106
T51.2
ICD-10 Finland
Toxic effect: 2-Propanol
+∞
10.4
10
*
N06AB05
ATC
paroxetine; oral
3.5
10.4
48
144
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
16.4
10.4
16
10
SPAT1247
SPAT
Outpatient detoxication and monitoring
33.1
10.4
13
*
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
19.1
10.3
15
8
T68
ICD-10 Finland
Hypothermia
19.1
10.3
15
8
N05CF02
ATC
zolpidem; oral
2.3
10.2
103
500
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
11.5
10.1
18
16
A46
ICD-10 Finland
Erysipelas
2.6
10.0
78
330
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
9.7
9.8
19
20
X78
ICD-10 Finland
Intentional self-harm by sharp object
9.7
9.8
19
20
N06AX16
ATC
venlafaxine; oral
2.2
9.8
102
502
N03AG01
ATC
valproic acid; systemic, rectal
3.1
9.7
52
175
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.4
9.6
34
81
S01.0
ICD-10 Finland
Open wound of scalp
3.0
9.6
55
194
N03AX09
ATC
lamotrigine; oral
3.1
9.3
49
164
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
13.9
9.2
15
11
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
7.9
9.2
20
26
F93.89
ICD-10 Finland
Other childhood emotional disorders
6.0
9.1
24
41
X58
ICD-10 Finland
Exposure to other specified factors
2.2
9.1
102
517
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
2.6
9.1
67
275
C07AA05
ATC
propranolol; systemic
2.0
9.1
128
711
Z72.2
ICD-10 Finland
Drug use
9.2
9.1
18
20
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
7.6
9.0
20
27
N06AX03
ATC
mianserin; oral
3.9
8.9
35
93
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
8.8
8.8
18
21
N03AE01
ATC
clonazepam; systemic
3.6
8.8
39
114
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.2
8.8
45
147
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
10.9
8.8
16
15
P29
ICPC
Psychological sympt/compl other
2.6
8.6
64
262
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
11.8
8.6
15
13
N05BE01
ATC
buspirone; oral
4.2
8.6
31
76
I51.7
ICD-10 Finland
Cardiomegaly
20.3
8.5
12
6
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
8.4
93
468
Y91.3
ICD-10 Finland
Very severe alcohol intoxication
+∞
8.3
8
*
N05AH02
ATC
clozapine; systemic
4.9
8.3
26
55
F10.07
ICD-10 Finland
Pathological alcohol intoxication
33.8
8.1
10
*
R5599
NOMESCO Finland
Other rehabilitation service
4.5
8.0
27
62
N05AF03
ATC
chlorprothixene; systemic
4.3
8.0
28
67
S00.0
ICD-10 Finland
Superficial injury of scalp
5.8
7.9
21
37
P99
ICPC
Psychological disorders other
3.9
7.8
31
83
N06AB10
ATC
escitalopram; oral
1.8
7.8
146
896
F91.9
ICD-10 Finland
Conduct disorder, unspecified
15.2
7.7
12
8
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.6
7.6
53
212
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
18.6
7.6
11
6
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
7.6
74
353
N40
ICD-10 Finland
Hyperplasia of prostate
0.3
7.5
23
617
T74.1
ICD-10 Finland
Physical abuse
4.3
7.4
26
63
F61.0
ICD-10 Finland
Mixed personality disorders
5.0
7.3
22
45
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
11.0
7.3
13
12
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
9.5
7.3
14
15
F10.06
ICD-10 Finland
Alcohol-related acute intoxication with seizures
+∞
7.3
7
*
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
15.9
7.2
11
7
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
15.9
7.2
11
7
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
15.9
7.2
11
7
V03AA01
ATC
NA
5.7
7.1
19
34
E87.6
ICD-10 Finland
Hypokalaemia
4.8
7.1
22
47
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.4
7.0
32
97
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
6.9
58
258
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
14.0
6.9
11
8
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.5
6.9
23
53
Z03
ICPC
Housing/neighbourhood problem
11.1
6.8
12
11
P18
ICPC
Medication abuse
9.4
6.8
13
14
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
40.5
6.8
8
*
K29.2
ICD-10 Finland
Alcoholic gastritis
40.5
6.8
8
*
F10.59
ICD-10 Finland
Alcohol psychosis, mixed type
40.5
6.8
8
*
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.9
6.7
26
69
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
22.8
6.7
9
*
S22.4
ICD-10 Finland
Multiple fractures of ribs
6.0
6.6
17
29
W19
ICD-10 Finland
Unspecified fall
2.2
6.6
67
325
Y04.8
ICD-10 Finland
Assault by bodily force by other known person
10.2
6.6
12
12
G72.8
ICD-10 Finland
Other specified myopathies
6.9
6.5
15
22
RS331
NOMESCO Finland
NA
70.5
6.4
7
*
Y90.8
ICD-10 Finland
Blood alcohol level of 240 mg/100 ml or more
70.5
6.4
7
*
F13.00
ICD-10 Finland
Intoxication caused by sedatives and hypnotics uncomplicated
70.5
6.4
7
*
X84
ICD-10 Finland
Intentional self-harm by unspecified means
14.5
6.4
10
7
F20
ICD-10 Finland
Schizophrenia
11.2
6.3
11
10
P98
ICPC
Psychosis NOS/other
9.4
6.3
12
13
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
9.4
6.3
12
13
N06AG02
ATC
moclobemide; oral
3.6
6.3
26
74
Z64.0
ICD-10 Finland
Problems related to unwanted pregnancy
3.6
6.3
26
74
R4140
NOMESCO Finland
Psychotherapy
7.1
6.2
14
20
TKC20
NOMESCO Finland
Catheterisation of bladder
2.5
6.2
44
180
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
8.7
6.1
12
14
Y07
ICD-10 Finland
Other maltreatment
6.8
6.1
14
21
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.0
6.0
80
434
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020191) Ethanol [Moles/volume] in Serum or Plasma
56
48
12.57
55.58
3.3
1.4
promille
1.6
1.3
0.53
42
37
(4198724)
51
47
11.61
48.23
2.4
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
103
252
4.61
39.45
4.6
2.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
550
6477
0.35
27.89
26.2
16.6
e9/l
7.2
6.8
4.91
536
6297
(3007461) Platelets [#/volume] in Blood
549
6467
0.36
27.60
26.2
16.6
e9/l
255.0
251.4
0.67
538
6300
(3026361) Erythrocytes [#/volume] in Blood
550
6473
0.35
27.56
26.1
16.6
e12/l
4.5
4.6
6.60
536
6298
(3024731) MCV [Entitic volume]
550
6471
0.36
27.40
26.0
16.5
fl
90.7
89.9
3.87
545
6379
(3035941) MCH [Entitic mass]
550
6471
0.36
27.40
26.0
16.5
pg
30.4
30.1
4.01
545
6378
(1001926) Buprenorphine [Presence] in Urine by Screen method
124
457
3.07
25.52
4.2
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
191
894
2.55
24.82
2.7
1.8
%
1.7
1.4
2.85
162
809
(3000764) Benzodiazepines [Presence] in Urine
140
572
2.80
23.79
4.2
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
110
395
3.11
23.59
4.9
2.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
133
536
2.82
23.16
4.2
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
140
581
2.75
23.04
4.2
1.8
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
27
29
9.64
22.76
1.5
3.6
umol/l
203.4
173.5
0.13
11
17
(3027008) Opiates [Presence] in Urine
137
579
2.69
21.67
4.1
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
135
568
2.70
21.54
4.2
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
97
413
2.56
14.85
7.9
4.1
mmol/l
2.4
1.7
0.75
71
317
(3021447) Carbon dioxide [Partial pressure] in Venous blood
97
417
2.53
14.55
6.1
4.1
kpa
5.9
5.8
0.59
87
399
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
416
5165
0.54
14.29
3.9
3.6
mmol/l
1.4
1.4
0.25
391
4840
(3042517) Benzodiazepines panel - Urine
13
10
13.22
13.40
2.0
3.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
397
4963
0.55
13.31
3.6
3.3
mmol/l
1.3
1.3
1.33
370
4636
(40761511) CBC panel - Blood by Automated count
521
6006
0.52
13.03
17.1
10.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
424
5187
0.55
12.86
3.9
3.6
mmol/l
4.5
4.6
0.89
393
4886
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
432
5255
0.55
12.80
4.0
3.9
mmol/l
2.7
2.7
1.61
396
4905
(3024354) Oxygen [Partial pressure] in Venous blood
82
351
2.51
12.37
6.5
3.2
kpa
4.9
4.6
0.42
72
335
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
60
231
2.74
11.18
8.3
4.2
mmol/l
23.6
24.0
0.47
53
215
(3000991) Gas panel - Venous blood
80
372
2.30
10.02
13.4
8.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
519
5900
0.56
9.94
11.8
8.6
u/l
31.9
27.6
2.93
506
5695
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
39
992
0.36
9.53
2.3
2.8
ug/l
0.6
0.7
0.90
23
593
(3003396) Base excess in Arterial blood by calculation
92
463
2.13
9.49
10.6
8.6
mmol/l
2.2
0.9
2.13
70
355
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
35
109
3.32
9.42
1.3
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
98
1711
0.51
9.10
3.2
4.4
ug/l
1.7
2.3
1.48
79
1538
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
70
1366
0.46
8.96
3.6
3.9
%
18.9
21.5
0.87
31
588
(3016650) Hepatitis A virus Ab [Presence] in Serum
34
117
3.00
7.80
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
431
5040
0.64
7.66
4.2
3.6
mmol/l
5.9
5.8
0.51
397
4626
(1761868) Lipid panel - Serum or Plasma
135
2052
0.58
7.52
2.4
2.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
217
1525
1.61
7.39
3.8
2.5
u/l
51.9
55.4
1.03
204
1403
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
437
5081
0.64
7.37
14.1
10.2
ml/min/173m2
101.5
92.2
11.23
349
4025
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
250
1818
1.58
7.36
4.4
3.2
u/l
34.7
31.3
0.83
237
1720
(3003338) MCHC [Mass/volume]
441
5117
0.64
7.36
21.7
14.4
g/l
334.7
334.2
0.58
435
5074
(3009542) Hematocrit [Volume Fraction] of Blood
487
5514
0.64
7.01
18.3
12.1
%
39.3
40.7
2.90
354
4375
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
192
1335
1.60
6.75
3.2
2.2
u/l
361.3
257.4
0.55
177
1256
(3017143) Hepatitis C virus Ab [Presence] in Serum
156
1032
1.65
6.70
2.1
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
506
5661
0.64
6.55
18.8
11.7
mg/l
20.4
22.7
0.89
415
4407
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
317
2475
1.50
6.55
6.5
5.8
umol/l
10.7
11.3
0.34
299
2321
(3004119) Hemoglobin [Mass/volume] in Venous blood
54
256
2.20
6.48
6.9
3.5
g/l
132.9
131.0
0.27
54
249
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
58
286
2.12
6.31
6.9
2.9
mmol/l
2.0
1.4
0.88
44
210
(3009343) pH of Capillary blood
60
302
2.08
6.19
6.7
2.9
ph
7.4
7.4
0.03
11
32
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
386
4529
0.68
5.96
5.8
4.7
mmol/mol
38.8
38.6
0.10
360
4264
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
394
4602
0.68
5.91
4.0
3.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
23
75
3.14
5.81
2.0
2.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
74
411
1.89
5.79
12.7
6.7
mmol/l
1.9
1.4
1.03
68
385
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
25
86
2.98
5.78
2.2
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
43
199
2.23
5.49
8.1
3.8
mmol/l
26.2
24.6
2.42
43
187
(3019060) Gas panel - Arterial blood
53
267
2.06
5.47
6.2
6.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
46
221
2.16
5.37
14.2
11.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
111
711
1.66
5.34
4.5
3.6
mmol/l
0.8
0.8
1.91
102
666
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
18
53
3.46
5.33
1.4
1.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
40
186
2.22
5.07
9.9
3.7
%
55.3
49.8
0.63
40
181
(3023368) Bacteria identified in Blood by Culture
177
1280
1.51
5.06
5.2
4.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
9
9
10.11
5.03
2.6
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
42
3.63
4.78
1.9
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
67
389
1.80
4.58
1.9
2.0
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
41
203
2.08
4.47
6.9
2.6
%
0.7
0.6
0.32
41
197
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
252
1992
1.41
4.43
11.6
5.6
mmol/l
1.2
1.2
3.78
232
1799
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
274
2203
1.39
4.34
10.9
6.3
mmol/l
1.2
1.2
3.18
232
1864
(1616796) Gas panel - Central venous blood
24
95
2.58
4.34
2.7
2.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
37
181
2.10
4.17
1.5
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
650
0.48
4.16
1.2
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
43
772
0.53
4.08
1.2
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
10
8.07
4.07
1.3
1.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
29
130
2.28
4.04
2.5
3.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
138
991
1.49
4.02
2.6
2.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
354
2994
1.36
4.01
8.0
4.6
mmol/l
6.7
6.5
0.57
319
2698
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
5
12.08
3.77
8.3
15.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
103
717
1.51
3.48
2.0
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
209
1664
1.36
3.36
3.3
2.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
33
169
2.00
3.34
1.6
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
23
102
2.30
3.32
2.4
1.7
nmol/l
0.9
0.8
0.26
17
88
(3023103) Potassium [Moles/volume] in Serum or Plasma
504
5463
0.74
3.27
20.3
12.6
mmol/l
3.9
3.9
4.32
486
5272
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
457
5021
0.75
3.24
5.3
4.3
mu/l
1.7
1.8
0.78
435
4655
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
48
282
1.75
3.21
1.8
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
503
5445
0.74
3.15
20.5
12.5
mmol/l
139.4
139.6
0.65
491
5268
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
206
1652
1.35
3.14
2.1
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
94
659
1.49
3.07
1.8
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
51
312
1.68
2.97
1.3
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
38
214
1.82
2.94
7.4
2.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
191
1528
1.34
2.93
3.0
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
163
1273
1.36
2.93
8.0
6.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
249
2073
1.31
2.88
2.9
2.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
450
4925
0.77
2.87
21.0
13.9
%
13.5
13.4
0.42
444
4831
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
71
476
1.55
2.87
3.6
2.4
u/l
38.4
31.7
0.32
60
394
(3024928) Oxygen saturation in Venous blood
21
96
2.22
2.86
2.4
3.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
153
1921
0.74
2.74
2.1
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
110
814
1.42
2.72
2.3
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
451
0.52
2.68
1.1
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
181
1455
1.33
2.67
3.1
2.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
32
178
1.84
2.60
1.8
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
38
2.92
2.59
2.6
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
102
752
1.42
2.58
1.8
1.7
nmol/l
1162.7
1149.0
0.05
80
581
(3020891) Body temperature
29
160
1.85
2.43
16.4
4.7
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
8
6.28
2.37
3.4
2.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
17
4.15
2.36
2.0
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
17
4.15
2.36
2.0
2.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
211
1763
1.28
2.30
7.2
7.1
inr
1.1
1.2
0.77
71
549
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
13
4.64
2.27
2.2
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
18
3.92
2.25
3.9
2.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
226
1911
1.27
2.23
5.5
4.9
g/l
35.9
36.5
0.87
211
1785
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
32
190
1.72
2.13
8.3
3.3
mmol/l
25.2
24.8
0.43
32
181
(3012501) Base excess in Blood by calculation
19
95
2.03
2.12
3.3
3.8
mmol/l
3.7
2.3
—
10
54
(3007853) Bacteria identified in Skin by Aerobe culture
86
639
1.39
2.10
2.2
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
112
1.90
1.98
1.4
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
47
315
1.53
1.96
1.4
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
50
0.00
1.89
0.0
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
8
28
2.88
1.86
4.5
1.5
mmol/l
10.5
9.0
—
8
22
(3019977) pH of Arterial blood
8
28
2.88
1.86
2.0
2.4
—
7.4
—
0
9
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
54
0.00
1.86
0.0
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
40
2.52
1.84
1.3
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
40
2.52
1.84
1.3
1.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
68
498
1.40
1.83
9.2
19.6
inr
1.0
1.3
—
5
81
(3009508) Creatinine [Moles/volume] in Urine
179
1506
1.25
1.81
4.8
3.1
mmol/l
7.7
8.6
1.47
159
1281
(3043238) Trisomy 21 risk [Likelihood] in Fetus
47
322
1.49
1.79
1.6
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
46
315
1.49
1.76
1.6
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
46
316
1.49
1.73
1.6
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
48
333
1.47
1.73
3.4
2.4
ug/l
5.5
8.4
0.84
40
294
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
13
3.86
1.71
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
111
1.82
1.70
1.5
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
48
335
1.46
1.68
2.3
2.8
e9/l
76.6
71.1
0.38
31
250
(3019150) Specific gravity of Urine by Refractometry
151
1257
1.25
1.67
4.9
3.3
kg/l
1.0
1.0
0.00
19
171
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
74
959
0.75
1.62
1.4
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
14
3.59
1.62
1.0
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
43
2.34
1.61
1.3
1.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
19
106
1.81
1.60
1.8
2.3
g/l
132.2
131.3
0.05
19
77
(3051651) Icteric interference index of Serum or Plasma
8
32
2.52
1.60
3.1
3.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
50
2.22
1.57
1.4
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
64
479
1.37
1.54
2.2
2.9
%
1.8
1.7
0.34
57
435
(3029396) Erythrocyte agglutination [Presence] in Blood
7
27
2.61
1.51
3.7
3.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
27
2.61
1.51
2.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
318
0.59
1.51
1.6
1.9
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
21
2.87
1.51
1.5
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
21
2.87
1.51
1.5
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
94
749
1.29
1.49
2.1
1.9
—
—
—
0
0
(3026782) Osmolality of Urine
119
979
1.26
1.46
2.9
2.6
mosm/kgh2o
503.1
581.9
2.89
107
839
(3011648) Oxygen content in Venous blood
9
38
2.39
1.46
1.9
2.4
%
10.9
11.9
—
9
38
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
52
2.13
1.45
1.6
3.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
103
834
1.27
1.44
4.2
3.3
ng/l
1915.6
486.2
0.57
64
545
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
110
1.75
1.44
3.3
3.8
%
53.8
55.7
0.37
19
110
(4024509)
9
39
2.32
1.43
1.7
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
357
3860
0.85
1.37
4.0
3.6
mm/h
9.2
9.7
0.32
330
3558
(42870588) Differential panel, method unspecified - Blood
202
1768
1.20
1.37
6.4
5.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
41
2.21
1.37
3.7
3.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
39
0.00
1.34
0.0
1.1
—
449.9
—
0
34
(3044290) Cell count panel - Cerebral spinal fluid
20
121
1.67
1.32
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
95
1157
0.79
1.30
3.7
3.4
mg/l
101.8
184.8
0.48
65
799
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
24
2.51
1.30
1.0
2.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
24
2.51
1.30
1.0
2.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
11
55
2.02
1.28
1.2
1.3
—
—
—
0
0
(4035726)
22
339
0.64
1.27
1.4
1.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
107
1.70
1.27
3.4
3.5
e9/l
3.5
4.1
0.93
18
107
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
30
203
1.50
1.26
1.3
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
22
338
0.64
1.26
1.5
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
62
480
1.32
1.23
4.4
2.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
45
2.01
1.23
1.0
1.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
67
525
1.30
1.23
2.0
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
56
1.98
1.22
1.3
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
124
1.63
1.22
1.3
1.4
ug/g
282.1
313.2
—
7
67
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
19
2.64
1.22
1.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
19
2.64
1.22
1.6
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
19
2.64
1.22
1.6
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
19
2.64
1.22
1.6
1.3
—
—
—
0
0
(44813793)
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
66
831
0.77
1.20
1.3
1.2
u/ml
3.8
8.4
0.84
22
330
(3008898) HLA-B27 [Presence]
17
271
0.62
1.16
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
141
1214
1.20
1.14
3.6
3.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
74
595
1.27
1.13
1.4
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
67
532
1.29
1.13
2.8
2.4
u/l
3045.8
4509.1
0.27
25
215
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
58
1.91
1.12
1.5
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
70
867
0.79
1.12
1.4
1.2
iu/ml
26.5
26.1
0.01
22
258
(3018418) pH of Serum or Plasma
151
1311
1.19
1.12
5.3
3.6
ph
7.4
7.4
0.07
31
240
(3044640) Blood type and Crossmatch panel - Blood
189
1674
1.18
1.11
2.4
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
249
2735
0.86
1.10
3.0
2.8
ug/l
82.7
97.9
0.65
233
2542
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
110
928
1.22
1.10
1.7
1.6
pmol/l
451.8
22110965.7
1.04
94
796
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
21
2.39
1.09
2.4
3.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
41
1.96
1.09
1.1
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
121
1.59
1.06
2.6
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
179
0.55
1.06
1.1
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
204
1826
1.16
1.05
2.0
1.8
pmol/l
95.4
94.8
0.07
124
978
(40768446) Kidney Pathology biopsy report
5
22
2.28
1.03
1.6
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
22
2.28
1.03
2.8
2.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
192
1715
1.16
1.01
4.1
3.3
ng/l
36.9
41.8
0.17
114
1007
(3021960) Folate [Moles/volume] in Serum or Plasma
119
1021
1.20
1.01
1.6
1.4
nmol/l
18.0
20.1
0.91
103
863
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
18
273
0.65
1.01
1.6
1.7
nmol/l
35.6
40.1
0.46
18
262
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
66
532
1.26
1.00
2.0
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
142
1618
0.85
1.00
3.1
2.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
157
1382
1.17
1.00
2.0
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
309
3325
0.88
1.00
3.2
3.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
5
23
2.18
0.98
2.0
1.3
mg/l
87.2
71.6
—
5
18
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
32
0.00
0.95
0.0
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
32
0.00
0.95
0.0
6.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
132
1150
1.18
0.95
1.8
1.9
mg/l
1.5
1.1
0.30
89
826
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
93
1.63
0.94
1.5
1.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
51
402
1.29
0.93
1.6
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
46
358
1.30
0.92
4.9
3.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
51
403
1.29
0.92
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
51
403
1.29
0.92
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
51
403
1.29
0.92
1.6
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
15
94
1.61
0.91
1.4
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
120
1045
1.18
0.87
2.5
2.4
e6/l
7.5
6.6
0.30
109
916
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
43
1.87
0.87
1.1
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
14
88
1.60
0.85
1.5
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
310
1.31
0.84
2.1
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
57
1.77
0.84
1.1
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
50
400
1.27
0.83
5.0
4.2
%
0.6
0.7
0.35
14
112
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
46
1.75
0.82
1.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
46
1.75
0.82
1.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
46
1.75
0.82
1.1
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
64
528
1.23
0.82
8.1
6.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
177
0.62
0.82
1.4
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
46
367
1.27
0.79
4.2
4.0
%
0.3
0.3
0.18
11
85
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
19
131
1.46
0.79
1.4
1.2
e6/l
211260.0
645.5
0.47
14
104
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
19
131
1.46
0.79
1.3
1.2
e6/l
37.1
10.9
0.34
14
99
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
144
1284
1.15
0.79
2.2
2.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
26
0.00
0.78
0.0
3.0
—
56.6
—
0
26
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
107
1221
0.85
0.78
1.6
1.6
mmol/l
1.7
1.4
2.19
95
1046
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
28
369
0.75
0.76
1.9
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
53
1.71
0.75
1.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
67
1.65
0.75
1.5
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
107
1215
0.86
0.74
4.7
4.1
mg/mmol
17.8
12.8
0.29
75
827
(3041354) Potassium [Moles/volume] in Venous blood
9
55
1.64
0.73
2.0
2.9
mmol/l
3.8
4.1
—
9
55
(3035285) Chloride [Moles/volume] in Venous blood
9
55
1.64
0.73
2.0
2.9
mmol/l
103.8
105.1
—
9
55
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
22
159
1.40
0.73
1.5
1.6
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
12
183
0.65
0.73
1.9
1.7
pmol/l
224.0
213.1
0.11
12
174
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
142
1.42
0.73
3.0
2.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
108
0.55
0.73
2.2
1.3
—
31.8
—
0
10
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
6
109
0.55
0.72
1.3
3.1
g/l
36.5
38.6
—
6
95
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
68
1.63
0.72
1.5
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
161
1458
1.13
0.71
2.8
3.1
mmol/l
2.3
2.3
0.72
140
1290
(3037121) Protein [Mass/volume] in Urine
25
186
1.36
0.71
4.3
3.5
g/l
0.4
0.3
0.14
12
86
(3017569) Oxygen content in Arterial blood
5
26
1.93
0.70
2.2
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
22
161
1.38
0.69
1.5
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
54
448
1.22
0.68
1.6
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
69
1.60
0.68
1.5
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
266
2486
1.11
0.68
7.2
5.7
%
0.7
0.6
0.48
247
2340
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
121
0.57
0.67
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
92
0.54
0.67
1.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
69
588
1.19
0.67
4.1
2.9
umol/l
6.5
9.1
1.02
56
495
(3007164) IgA [Mass/volume] in Serum or Plasma
148
1338
1.13
0.67
1.5
1.4
g/l
2.1
2.3
0.96
87
839
(3018095) Leukocytes [#/volume] in Urine
203
1871
1.12
0.67
3.7
3.4
e6/l
46.7
77.3
0.50
137
1255
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
197
1.33
0.66
2.1
2.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
25
327
0.76
0.66
1.4
1.3
—
31.1
—
0
16
(3019069) Monocytes/100 leukocytes in Blood
276
2592
1.11
0.64
7.3
5.8
%
8.3
8.4
0.30
257
2451
(3045414) Leukocytes [Presence] in Urine
16
223
0.71
0.63
1.6
1.6
—
—
—
0
0
(3019225) pH of Specimen
51
425
1.22
0.63
6.0
3.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
26
335
0.77
0.63
2.8
2.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
79
1.53
0.63
1.5
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
49
1.64
0.62
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
46
381
1.22
0.61
5.3
4.2
%
0.1
0.1
0.14
11
103
(36304419) Bacteria [Presence] in Urine
150
1367
1.12
0.60
3.1
2.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
400
3834
1.10
0.60
8.7
6.8
u/l
74.1
74.9
0.19
380
3580
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
53
1.52
0.58
1.4
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
7
113
0.62
0.58
1.3
3.3
g/l
0.0
0.8
—
7
103
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
475.0
—
0
12
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.0
—
34.3
—
0
10
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
251.1
—
0
12
(3006504) Eosinophils/100 leukocytes in Blood
273
2577
1.10
0.56
7.2
5.6
%
2.6
2.8
0.93
252
2416
(4268621)
11
73
1.51
0.56
2.3
2.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
27
340
0.79
0.56
1.3
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
183
0.71
0.56
1.3
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
37
1.63
0.55
1.7
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
60
516
1.18
0.55
1.2
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
286
2710
1.09
0.54
7.0
5.5
%
28.5
29.2
0.49
267
2560
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
259
1.25
0.53
2.1
1.6
—
—
—
0
0
(3013512) EKG study
136
1244
1.12
0.52
4.3
3.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
9
63
1.43
0.52
6.1
6.2
mg/l
9.0
10.2
—
9
57
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
134
0.67
0.52
1.7
2.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
270
0.77
0.52
1.1
1.5
mg/l
4.0
3.6
0.07
13
185
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
63
722
0.86
0.52
2.2
1.9
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
40
1.50
0.51
1.8
2.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
32
389
0.81
0.50
1.5
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
41
1.47
0.50
1.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
67
1.50
0.50
1.5
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
67
1.50
0.50
1.5
1.3
—
—
—
0
0
(4010399)
38
317
1.21
0.49
1.3
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
155
0.71
0.49
3.2
2.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
190
2029
0.91
0.48
1.8
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
181
1.28
0.48
2.4
2.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
222
0.76
0.48
4.4
3.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
48
411
1.18
0.48
1.1
1.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
288
2743
1.08
0.47
7.1
5.4
e9/l
0.0
0.0
0.05
250
2406
(4146454)
7
47
1.49
0.47
3.3
2.9
—
—
—
0
0
(4062490)
7
47
1.49
0.47
1.6
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
43
365
1.19
0.47
5.4
4.3
%
0.0
0.1
0.82
12
90
(3001604) Monocytes [#/volume] in Blood
287
2734
1.08
0.47
7.0
5.4
e9/l
0.6
0.6
0.75
248
2392
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
68
1.48
0.47
1.5
1.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
23
182
1.27
0.47
3.6
2.7
%
98.6
89.4
1.50
23
172
(3030467) Casts [#/volume] in Urine by Automated count
150
1389
1.10
0.46
3.3
2.9
e6/l
0.4
0.4
0.03
120
1027
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
29
352
0.82
0.46
2.4
2.3
—
17.3
—
0
25
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
120
0.66
0.46
1.8
3.0
g/l
12.9
10.3
—
8
110
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
143
1323
1.10
0.45
2.5
2.0
mg/l
2.9
2.8
0.08
121
1118
(3035637) Corticotropin [Mass/volume] in Plasma
7
50
1.40
0.45
1.0
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
53
461
1.16
0.44
1.2
1.3
iu/ml
147.2
129.7
0.09
19
174
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
51
1.38
0.44
1.4
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
95
1.38
0.44
1.2
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
327
3139
1.08
0.43
11.5
8.1
e9/l
4.3
4.1
1.12
280
2747
(3019198) Lymphocytes [#/volume] in Blood
299
2863
1.08
0.42
6.9
5.4
e9/l
2.0
2.0
0.02
262
2552
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
122
1.32
0.42
1.5
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
33
1.52
0.41
2.4
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
60
531
1.14
0.41
1.5
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
59
1.36
0.41
1.6
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
10
138
0.72
0.40
1.8
1.3
—
33.5
—
0
8
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
108.4
—
0
12
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(4133840)
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
55
485
1.15
0.40
1.8
1.9
nmol/l
377.5
395.8
0.20
50
438
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
97
1.35
0.39
2.1
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
8
61
1.31
0.39
2.0
1.9
nmol/l
20.9
23.1
—
8
56
(3035880) pH of Pleural fluid
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
91
831
1.11
0.38
2.2
2.4
ug/g
121.1
118.6
0.03
67
650
(44790048)
9
67
1.35
0.38
1.4
1.6
—
—
—
0
0
(44790047)
9
67
1.35
0.38
1.4
1.6
—
—
—
0
0
(44790049)
9
67
1.35
0.38
1.4
1.6
—
—
—
0
0
(44806118)
9
67
1.35
0.38
1.4
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
68
1.33
0.37
1.2
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
112
0.71
0.37
2.1
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
107
1.31
0.37
3.7
3.4
u/ml
0.3
0.3
—
8
54
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
116
0.69
0.37
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
204
2146
0.93
0.36
3.9
3.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
187
1770
1.08
0.36
3.9
3.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
78
0.64
0.35
1.4
1.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
44
1.37
0.34
1.8
2.0
ug/l
19.4
17.3
—
6
44
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
45
1.34
0.34
1.7
1.8
pg
32.0
33.6
—
6
45
(3018010) Neutrophils/100 leukocytes in Blood
278
2675
1.06
0.33
6.9
5.4
%
56.9
56.2
0.44
260
2531
(3013115) Eosinophils [#/volume] in Blood
293
2826
1.06
0.32
8.0
5.7
e9/l
0.2
0.2
0.60
255
2515
(21494815) CD4 cells/100 lymphocytes in Specimen
6
47
1.28
0.32
2.3
1.9
—
41.8
—
0
5
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
52
579
0.89
0.32
4.4
3.7
%
33.3
31.1
0.75
39
406
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
13
101
1.29
0.32
1.5
1.3
u/ml
9.8
4.8
—
8
44
(3000492) Spirometry study
51
568
0.89
0.31
1.3
1.4
—
—
—
0
0
(1002224) Polysomnography panel
20
240
0.83
0.31
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
98
0.71
0.31
1.6
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
142
0.77
0.31
2.5
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
53
1.32
0.31
2.3
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
37
325
1.15
0.30
1.4
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
84
1.31
0.30
1.1
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
55
1.28
0.30
2.3
2.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
157
1.22
0.29
1.7
1.3
u/ml
202.0
234.7
0.26
12
96
(3009214) Lutropin [Units/volume] in Serum or Plasma
25
292
0.85
0.29
1.3
1.4
u/l
11.3
7.5
0.43
20
245
(3023323) Follitropin [Units/volume] in Serum or Plasma
22
260
0.84
0.29
1.5
1.4
iu/l
9.8
13.9
0.46
17
213
(3037467) Urinalysis macro (dipstick) panel - Urine
373
3828
0.95
0.29
4.9
3.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
39
345
1.14
0.29
1.2
1.4
miu/ml
61.1
275.4
—
8
175
(3050129) First trimester maternal screen panel - Serum or Plasma
47
523
0.89
0.29
1.3
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
106
0.75
0.29
1.4
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
57
1.23
0.29
1.1
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
112
1193
0.93
0.29
2.8
2.6
umol/l
3472.3
4973.0
0.18
100
1057
(42529406) Shigella sp [Presence] in Stool by Culture
14
173
0.81
0.28
1.2
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
269
2781
0.95
0.27
3.7
3.2
estimate
0.0
0.0
0.00
58
550
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
64
1.25
0.27
1.4
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
401
3918
1.05
0.27
5.3
2.9
u/l
49.6
42.1
1.24
384
3714
(3037756) Immunofixation for Serum or Plasma
8
65
1.23
0.27
1.6
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
11
139
0.79
0.27
1.0
1.1
u/ml
0.2
1.5
—
5
67
(3037522) Nuclear Ab [Titer] in Serum
78
724
1.09
0.26
1.4
1.4
titre
231.1
473.9
—
9
131
(3004588) Protein electrophoresis panel - Serum or Plasma
19
224
0.84
0.25
3.7
2.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
170
0.82
0.25
1.2
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
161
1538
1.06
0.25
3.2
3.0
e6/l
70.8
102.7
0.26
130
1176
(3002256) Pathology report gross observation
53
579
0.91
0.25
1.3
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
30
339
0.88
0.24
3.2
2.5
ml/min/173m2
73.2
74.9
0.06
13
134
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
169
0.82
0.24
1.2
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
268
2601
1.05
0.23
4.6
4.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
352
1.11
0.23
1.3
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
40
1.25
0.22
1.0
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
79
1.27
0.22
1.4
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.2
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
124
1301
0.94
0.22
5.2
4.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
155
1486
1.05
0.22
1.4
1.3
u/ml
3.6
1.8
0.28
44
398
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
357
3646
0.96
0.21
5.2
3.9
e6/l
92.6
1726.3
—
5
48
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
12
0.00
0.21
0.0
1.8
—
4377.8
—
0
6
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
144
1501
0.95
0.20
4.0
3.3
estimate
0.0
0.0
1.08
58
563
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
410
4171
0.96
0.20
4.3
3.6
pmol/l
14.7
14.6
0.51
387
3783
(3042631) Mycobacterium sp identified in Specimen
6
52
1.16
0.19
4.3
3.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
87
825
1.06
0.18
2.8
2.5
e6/l
1.6
0.9
0.56
48
457
(3023419) Bacteria identified in Sputum by Culture
7
58
1.21
0.18
2.4
3.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
23
258
0.89
0.18
2.3
2.6
e6/l
0.4
0.1
0.74
23
247
(3013139) Helicobacter pylori Ag [Presence] in Stool
35
320
1.10
0.17
1.3
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
10
82
1.22
0.17
2.0
1.8
g/l
0.6
0.8
—
5
64
(3021601) Nitrite [Presence] in Urine by Test strip
268
2742
0.96
0.17
5.1
4.4
estimate
0.0
0.0
0.50
61
582
(3021788) Differential panel - Synovial fluid
7
63
1.11
0.17
2.4
1.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
70
661
1.07
0.17
2.8
2.2
g/l
2.5
2.4
0.73
61
600
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
167
1.14
0.17
2.5
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
55
515
1.07
0.16
4.4
3.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
68
1.18
0.16
1.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
69
1.16
0.16
8.1
2.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
207
2016
1.04
0.15
2.6
2.2
nmol/l
68.2
71.1
0.76
187
1821
(3005322) IgE [Units/volume] in Serum or Plasma
34
369
0.92
0.15
1.3
1.3
u/ml
127.9
317.8
1.66
27
344
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
12
102
1.18
0.15
1.2
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
192
0.88
0.15
1.5
2.1
u/ml
22.4
44.4
0.95
17
183
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
171
0.87
0.15
5.8
2.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
38
353
1.08
0.14
1.9
3.5
pmol/l
4.7
4.7
0.01
33
317
(4094501)
10
118
0.85
0.14
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
122
1.15
0.14
1.4
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
99
0.81
0.13
3.3
2.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
201
0.89
0.13
1.6
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
65
618
1.06
0.13
1.4
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
40
375
1.07
0.12
3.0
2.2
e9/l
4.2
4.1
0.09
31
311
(3021589) Normoblasts [#/volume] in Blood
249
2445
1.03
0.12
12.2
8.1
e9/l
0.0
0.0
0.56
210
1990
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
95
1.16
0.11
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
95
1.16
0.11
1.4
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
143
1.12
0.11
1.6
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
789
1.04
0.11
2.8
2.7
e6/l
6.0
2.4
1.17
43
426
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
86
1.17
0.11
1.4
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
18
163
1.11
0.11
1.7
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
135
0.89
0.10
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
135
0.89
0.10
1.3
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
15
166
0.90
0.10
1.1
1.1
u/ml
1.3
1.2
—
7
68
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
63
605
1.05
0.10
2.9
2.3
%
23.5
24.4
0.17
55
528
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
169
1656
1.03
0.09
1.9
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
271
2748
0.98
0.09
3.6
3.2
estimate
0.0
0.0
0.00
58
563
(40765089) Chromosome analysis panel - Blood by G-banded
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
72
743
0.97
0.08
2.3
2.8
mmol/l
2.4
2.4
0.46
55
643
(3003327) Ova and parasites identified in Stool by Light microscopy
22
205
1.08
0.08
1.5
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
68
1.03
0.08
1.1
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
100
1025
0.97
0.07
1.6
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
85
1.06
0.07
1.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
85
1.06
0.07
1.1
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
89
1.13
0.07
1.4
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
93
0.86
0.06
1.1
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
9
103
0.87
0.06
7.2
3.4
—
1.4
—
0
11
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
80
820
0.97
0.06
1.6
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
42
434
0.97
0.05
1.4
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
73
716
1.02
0.04
2.6
2.2
umol/l
14.3
14.2
0.04
66
652
(3020961) Endomysium IgA Ab [Titer] in Serum
31
321
0.96
0.03
1.0
1.1
—
138.7
—
0
7
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
108
1094
0.98
0.03
3.0
3.0
ng/l
1621.6
1338.0
0.18
92
894
(4306422)
10
92
1.09
0.03
1.0
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
12
127
0.94
0.01
1.7
2.0
mg/l
11.1
11.4
0.08
12
121
(4034850)
17
165
1.03
0.00
7.1
9.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
134
0.97
0.00
1.2
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
143
0.98
0.00
1.0
1.1
u/ml
11.4
7.0
—
9
87
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
10
98
1.02
0.00
1.3
1.5
u/l
28.3
15.0
—
10
87
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
102
0.98
0.00
1.1
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
112
0.98
0.00
4.5
4.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
202
0.99
0.00
1.6
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
171
0.99
0.00
1.2
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
2.0
—
0
7
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
3.3
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
10.8
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
72.7
—
0
5
(3033799) Differential panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
53
0.94
0.00
1.0
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
5
55
0.91
0.00
4.4
1.3
mu/l
50.1
34.0
—
5
48
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
51
0.98
0.00
1.4
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
9
0.00
0.00
0.0
3.0
—
8363.6
—
0
9
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
77
0.91
0.00
1.4
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
68
0.88
0.00
1.2
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
67
0.89
0.00
1.5
1.7
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
9
91
0.99
0.00
1.0
1.2
%
122.4
112.5
—
9
85
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
69
0.87
0.00
1.7
1.7
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
73
0.96
0.00
9.6
3.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
9
0.00
0.00
0.0
1.1
—
3.0
—
0
9
(4038314)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
61
0.98
0.00
1.3
1.2
nmol/l
46.4
37.3
—
6
56
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
54
0.93
0.00
1.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.2
—
0.3
—
0
6
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
8.8
—
0
5
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
64
0.94
0.00
1.2
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
66
0.91
0.00
1.2
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
89
0.90
0.00
1.6
1.3
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.3
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_ACCIDENTAL_POISO_EXPOS_ALCOHOL – Accidental poisoning by and exposure to alcohol
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).